This electrochemical aptamer-based biosensor could detect 0.08 ng/mL of PSA and 0.15 ng/mL of VEGF, released in vitro by three different prostate cancer cell lines (RWPE-1, LNCaP, and PC3). This evidence concerns the gene VEGFA and prostate cancer.